BioTime Inc. buy melinda
Start price
26.06.17
/
50%
€2.84
Target price
26.12.17
€3.40
Performance (%)
-32.36%
End price
26.12.17
€1.92
Summary
This prediction ended on 26.12.17 with a price of €1.92. Massive losses of -32.36% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| BioTime Inc. | - | - | - | - |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% | 65.851% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% | 93.298% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% | 89.079% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% | 71.942% |
Comments by melinda for this prediction
In the thread BioTime Inc. diskutieren
zu folgen
AST-OPC1 - SCiStar
Zervikale Rückenmark
(Laufzeit überschritten)


